citric acid, anhydrous has been researched along with Hyperoxaluria in 44 studies
Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.
Hyperoxaluria: Excretion of an excessive amount of OXALATES in the urine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment of ethylene glycol intoxication is based on specific inhibitors of alcohol dehydrogenase and hemodialysis in the most severe forms, and should be started promptly." | 5.39 | [Secondary hyperoxaluria and nephrocalcinosis due to ethylene glycol poisoning]. ( Harambat, J; Llanas, B; Missonnier, S; Monet, C; Rebouissoux, L; Richard, E, 2013) |
| " Metabolic abnormalities were significantly more present in patients with mixed infected stones (struvite+/-apatite and calcium oxalate) than in patients with pure infected stones (struvite+/-carbonate apatite): hypercalciuria in 40%, hyperoxaluria in 34% and hyperuricosuria in 28% (p < 0." | 3.83 | Metabolic evaluation in patients with infected nephrolithiasis: Is it necessary? ( Cicerello, E; Cova, GD; Maccatrozzo, L; Mangano, M; Merlo, F, 2016) |
| "We used computer modeling to investigate the influence of physicochemical stone risk factors on urinary supersaturation (SS) of calcium oxalate (CaOx) in patients with severe hyperoxaluria, relative hypocalciuria, hypocitraturia, and CaOx nephrolithiasis after extensive small bowel resection, usually performed for Crohn's disease." | 3.80 | Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols. ( Allie-Hamdulay, S; Jackson, GE; Rodgers, AL; Sutton, RA, 2014) |
| "Metabolic syndrome trait clustering is associated with greater severity of kidney stone disease; increased urinary calcium, uric acid, and oxalate excretion; and decreased urinary citrate excretion." | 3.79 | Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan. ( Hara, I; Iguchi, M; Inagaki, T; Kohjimoto, Y; Matsumura, N; Sasaki, Y, 2013) |
| " In our study, calcium and uric acid abnormalities were the most common, and vesicoureteral reflux seemed to be the most common urological abnormality which led to urinary stasis and calculus formation." | 3.76 | Metabolic factors associated with urinary calculi in children. ( Alamdaran, SA; Naseri, M; Varasteh, AR, 2010) |
| "5), hypercalciuria-calcium greater than 200 mg, hyperoxaluria-oxalate greater than 45 mg, hyperuricosuria-uric acid greater than 600 mg, hypocitraturia-citrate less than 600 mg and purine gluttony-sulfate greater than 20 mg." | 3.73 | Ethnic background has minimal impact on the etiology of nephrolithiasis. ( Ekeruo, WO; Enemchukwu, CU; Maloney, ME; Preminger, GM; Springhart, WP; Young, MD, 2005) |
| "l-Arg could act as a potent antilithic agent, by increasing the level of citrate in the hyperoxaluria-induced rats and decreasing calcium oxalate binding to the THP." | 3.73 | Oral L-arginine supplementation ameliorates urinary risk factors and kinetic modulation of Tamm-Horsfall glycoprotein in experimental hyperoxaluric rats. ( Kalaiselvi, P; Pragasam, V; Srinivasan, S; Sumitra, K; Varalakshmi, P, 2005) |
| "Twenty-four rats were divided into four groups of six rats each; those in Group I served as controls, those in Group II had hyperoxaluria induced using sodium glycollate, those in Group III were given cysteine alone and those in Group IV were given sodium glycollate and cysteine." | 3.69 | Effect of L-cysteine on some urinary risk factors in experimental hyperoxaluric rats. ( Saravanan, N; Senthil, D; Varalakshmi, P, 1996) |
| "In both groups hyperoxaluria was the most common abnormality, followed by hypercalciuria." | 2.80 | Oxalobacter formigenes: Opening the door to probiotic therapy for the treatment of hyperoxaluria. ( Desai, M; Ganpule, A; Jairath, A; Mishra, S; Otano, N; Parekh, N; Sabnis, R, 2015) |
| "Oxaluria was decreased 21." | 2.67 | Effect of unprocessed wheat bran on calciuria and oxaluria in patients with urolithiasis. ( Gleeson, MJ; Griffith, DP; Mehta, S; Thompson, AS, 1990) |
| "Childhood urolithiasis is an evolving condition with an increasing incidence and prevalence over the last 2 decades." | 2.48 | Urolithiasis in children: medical approach. ( Copelovitch, L, 2012) |
| "Urolithiasis is a worldwide problem with significant health and economic burdens." | 2.47 | Pharmacotherapy of urolithiasis: evidence from clinical trials. ( Moe, OW; Pearle, MS; Sakhaee, K, 2011) |
| "Kidney stones are associated with various biochemical disturbances in urine." | 2.44 | Pharmacotherapy of kidney stones. ( Pak, CY, 2008) |
| " Metabolic study consisted of two 24-h urine collections separated by a period of 3 months for dosing Ca, P, uric acid, Na, K, Mg, oxalate, and citrate." | 1.42 | An update on metabolic assessment in patients with urinary lithiasis. ( Amaro, CR; Amaro, JL; Damasio, PC; Goldberg, J; Leitão, VA; Padovani, CR; Turney, B, 2015) |
| "Hypercalciuria, hypocitraturia, hyperoxaluria, hyperuricosuria, and cystinuria were detected in 41%, 39%, 22%, 9%, and 4% of the patients, respectively." | 1.42 | Metabolic disorders in Turkish children with urolithiasis. ( Aydogan, G; Celiksoy, MH; Kiyak, A; Sander, S; Topal, E; Yilmaz, A, 2015) |
| "Treatment of ethylene glycol intoxication is based on specific inhibitors of alcohol dehydrogenase and hemodialysis in the most severe forms, and should be started promptly." | 1.39 | [Secondary hyperoxaluria and nephrocalcinosis due to ethylene glycol poisoning]. ( Harambat, J; Llanas, B; Missonnier, S; Monet, C; Rebouissoux, L; Richard, E, 2013) |
| "Hyperoxaluria, hypernatruria, and hypercalciuria were found in 84 (77%), 43 (39." | 1.39 | Effects of dietary interventions on 24-hour urine parameters in patients with idiopathic recurrent calcium oxalate stones. ( Aksakal, N; Bozkırlı, I; Gülbahar, O; Irkilata, L; Karaoğlan, U; Kıraç, M; Küpeli, B, 2013) |
| "Nephrolithiasis was confirmed radiographically in 39/56 patients (69." | 1.38 | Nephrolithiasis in medullary sponge kidney: evaluation of clinical and metabolic features. ( Gettman, MT; Krambeck, AE; McPhail, EF; Patterson, DE; Rangel, LJ, 2012) |
| "Hypercalciuria was detected in 9/47, hyperoxaluria in 5/39, hypocitraturia in 4/31, and cystinuria in 2/50 infants." | 1.36 | Urolithiasis in the first year of life. ( Akbas, H; Akman, S; Alimoglu, E; Baysal, YE; Güven, AG; Kabaalioglu, A; Koyun, M, 2010) |
| "Urolithiasis is one of the commonest problems in pediatric nephrology." | 1.36 | Clinical manifestations and etiology of renal stones in children less than 14 years age. ( Heidari, A; Sepahi, MA; Shajari, A, 2010) |
| "The prevalence of hyperoxaluria (47% vs 10." | 1.36 | Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery. ( Guth, ES; Livingston, EH; Maalouf, NM; Sakhaee, K; Tondapu, P, 2010) |
| "Hyperuricosuria, hyperoxaluria and a low urinary volume did not influence the risk for active stone formation." | 1.33 | Risk factors determining active urinary stone formation in patients with urolithiasis. ( Netelenbos, JC; ter Wee, PM; Zwijnenburg, PJ, 2005) |
| "The primary hyperoxalurias are autosomal recessive disorders resulting from deficiency of hepatic alanine:glyoxylate aminotransferase (PHI) or D-glycerate dehydrogenase/glyoxylate reductase (PHII)." | 1.31 | Phenotypic expression of primary hyperoxaluria: comparative features of types I and II. ( Milliner, DS; Smith, LH; Wilson, DM, 2001) |
| "The frequency of hyperoxaluria did not differ between cases and controls, but was three times more common among men compared with women." | 1.31 | Twenty-four-hour urine chemistries and the risk of kidney stones among women and men. ( Curhan, GC; Speizer, FE; Stampfer, MJ; Willett, WC, 2001) |
| "Hyperoxaluria was reported to induce renal damage, probably due to toxic effects on renal tubules." | 1.30 | N-acetyl-beta-D-glucosaminidase excretion in healthy children and in pediatric patients with urolithiasis. ( Abdalmotaal, E; Balla, AA; Bongartz, D; Hesse, A; Hoppe, B; Kessler, T; Salah, AM, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (20.45) | 18.2507 |
| 2000's | 10 (22.73) | 29.6817 |
| 2010's | 24 (54.55) | 24.3611 |
| 2020's | 1 (2.27) | 2.80 |
| Authors | Studies |
|---|---|
| Huynh, LM | 1 |
| Dianatnejad, S | 1 |
| Tofani, S | 1 |
| Carrillo Ceja, R | 1 |
| Liang, K | 1 |
| Tapiero, S | 1 |
| Jiang, P | 1 |
| Youssef, RF | 1 |
| Otto, BJ | 1 |
| Bozorgmehri, S | 1 |
| Kuo, J | 1 |
| Canales, M | 1 |
| Bird, VG | 1 |
| Canales, B | 1 |
| Khan, A | 1 |
| Kohjimoto, Y | 1 |
| Sasaki, Y | 1 |
| Iguchi, M | 1 |
| Matsumura, N | 1 |
| Inagaki, T | 1 |
| Hara, I | 1 |
| Monet, C | 1 |
| Richard, E | 1 |
| Missonnier, S | 1 |
| Rebouissoux, L | 1 |
| Llanas, B | 1 |
| Harambat, J | 1 |
| Cunha, NB | 1 |
| Kawano, PR | 1 |
| Padovani, CR | 2 |
| Lima, Fde O | 1 |
| Bernardes, S | 1 |
| Magalhães, ES | 1 |
| Amaro, CR | 2 |
| Amaro, JL | 2 |
| Ishii, K | 1 |
| Sugimoto, T | 1 |
| Kanazawa, T | 1 |
| Yoneda, Y | 1 |
| Kamikawa, S | 1 |
| Limori, H | 1 |
| Nakatani, T | 1 |
| Yamamoto, K | 1 |
| Kishimoto, T | 1 |
| Wu, W | 1 |
| Yang, D | 1 |
| Tiselius, HG | 1 |
| Ou, L | 1 |
| Liang, Y | 1 |
| Zhu, H | 1 |
| Li, S | 1 |
| Zeng, G | 1 |
| Goldberg, J | 1 |
| Damasio, PC | 1 |
| Leitão, VA | 1 |
| Turney, B | 1 |
| Rodgers, AL | 1 |
| Allie-Hamdulay, S | 1 |
| Jackson, GE | 1 |
| Sutton, RA | 1 |
| Ferraro, PM | 1 |
| Robertson, WG | 1 |
| Johri, N | 1 |
| Nair, A | 1 |
| Gambaro, G | 1 |
| Shavit, L | 1 |
| Moochhala, SH | 1 |
| Unwin, RJ | 1 |
| Jairath, A | 1 |
| Parekh, N | 1 |
| Otano, N | 1 |
| Mishra, S | 1 |
| Ganpule, A | 1 |
| Sabnis, R | 1 |
| Desai, M | 1 |
| Celiksoy, MH | 1 |
| Yilmaz, A | 1 |
| Aydogan, G | 1 |
| Kiyak, A | 1 |
| Topal, E | 1 |
| Sander, S | 1 |
| Cicerello, E | 1 |
| Mangano, M | 1 |
| Cova, GD | 1 |
| Merlo, F | 1 |
| Maccatrozzo, L | 1 |
| Pak, CY | 1 |
| Alpay, H | 1 |
| Ozen, A | 1 |
| Gokce, I | 1 |
| Biyikli, N | 1 |
| Güven, AG | 1 |
| Koyun, M | 1 |
| Baysal, YE | 1 |
| Akman, S | 1 |
| Alimoglu, E | 1 |
| Akbas, H | 1 |
| Kabaalioglu, A | 1 |
| Sepahi, MA | 1 |
| Heidari, A | 1 |
| Shajari, A | 1 |
| Naseri, M | 1 |
| Varasteh, AR | 1 |
| Alamdaran, SA | 1 |
| Maalouf, NM | 1 |
| Tondapu, P | 1 |
| Guth, ES | 1 |
| Livingston, EH | 1 |
| Sakhaee, K | 2 |
| Moe, OW | 1 |
| Pearle, MS | 1 |
| Gürgöze, MK | 1 |
| Sarı, MY | 1 |
| McPhail, EF | 1 |
| Gettman, MT | 1 |
| Patterson, DE | 1 |
| Rangel, LJ | 1 |
| Krambeck, AE | 1 |
| McMahon, GM | 1 |
| Seifter, JL | 1 |
| Arrabal-Polo, MA | 1 |
| Arias-Santiago, S | 1 |
| Girón-Prieto, MS | 1 |
| Abad-Menor, F | 1 |
| López-Carmona Pintado, F | 1 |
| Zuluaga-Gomez, A | 1 |
| Arrabal-Martin, M | 1 |
| Copelovitch, L | 1 |
| Eisner, BH | 1 |
| Sheth, S | 1 |
| Dretler, SP | 1 |
| Herrick, B | 1 |
| Pais, VM | 1 |
| Kıraç, M | 1 |
| Küpeli, B | 1 |
| Irkilata, L | 1 |
| Gülbahar, O | 1 |
| Aksakal, N | 1 |
| Karaoğlan, U | 1 |
| Bozkırlı, I | 1 |
| Parmar, MS | 1 |
| Netelenbos, JC | 1 |
| Zwijnenburg, PJ | 1 |
| ter Wee, PM | 1 |
| Maloney, ME | 1 |
| Springhart, WP | 1 |
| Ekeruo, WO | 1 |
| Young, MD | 1 |
| Enemchukwu, CU | 1 |
| Preminger, GM | 1 |
| Pragasam, V | 1 |
| Kalaiselvi, P | 1 |
| Sumitra, K | 1 |
| Srinivasan, S | 1 |
| Varalakshmi, P | 2 |
| Pasch, A | 1 |
| Sarica, K | 1 |
| Akarsu, E | 1 |
| Erturhan, S | 1 |
| Yagci, F | 1 |
| Aktaran, S | 1 |
| Altay, B | 1 |
| Buchman, AL | 1 |
| Moukarzel, AA | 1 |
| Ament, ME | 1 |
| Campoy Martínez, P | 1 |
| Reina Ruiz, C | 1 |
| Salazar Murillo, R | 1 |
| Quintero Rodríguez, R | 1 |
| Espinosa Olmedo, FJ | 1 |
| García Pérez, M | 1 |
| Saravanan, N | 1 |
| Senthil, D | 1 |
| Hess, B | 1 |
| Schenkman, NS | 1 |
| Stoller, ML | 1 |
| Balla, AA | 1 |
| Salah, AM | 1 |
| Abdalmotaal, E | 1 |
| Hoppe, B | 1 |
| Bongartz, D | 1 |
| Kessler, T | 1 |
| Hesse, A | 1 |
| Milliner, DS | 1 |
| Wilson, DM | 1 |
| Smith, LH | 1 |
| Curhan, GC | 1 |
| Willett, WC | 1 |
| Speizer, FE | 1 |
| Stampfer, MJ | 1 |
| Solomons, CC | 1 |
| Melmed, MH | 1 |
| Heitler, SM | 1 |
| Gleeson, MJ | 1 |
| Thompson, AS | 1 |
| Mehta, S | 1 |
| Griffith, DP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Apple Cider Vinegar for the Prevention of Urinary Lithiasis (APUL)[NCT04073719] | 50 participants (Anticipated) | Interventional | 2019-09-01 | Not yet recruiting | |||
| Retrograde Intrarenal Surgery Results and Stone-free Rate in Children With Kidney Stones[NCT06138704] | 105 participants (Actual) | Observational [Patient Registry] | 2019-01-01 | Completed | |||
| Variation in Urine Electrolytes, pH and Specific Gravity Throughout the Day and the Effect of Increased Fluid Intake on Intra-Day Urine Composition[NCT03645785] | 23 participants (Actual) | Interventional | 2018-08-28 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Ca/Cr at 4 voids throughout the day. Pre = baseline fluid intake; Post = increased fluid and citrate supplementation (NCT03645785)
Timeframe: Day 1 (first void, 9-10 am, 1-2 pm and 5 pm) and Day 4 (first void, 9-10 am, 1-2 pm and 5 pm)
| Intervention | Ratio (Mean) |
|---|---|
| 5pm Void Post | 0.162234 |
| 5p.m. Pre | 0.161287 |
| 1-2 pm Post | 0.137398 |
| 1-2pm Void Pre | 0.140431 |
| 9-10AM Post | 0.126269 |
| 9-10AM Pre | 0.111446 |
| First Void Pre | 0.160932 |
| First Void Post | 0.142987 |
Citrate/Cr at 4 voids throughout the day. Pre = baseline fluid intake; Post = increased fluid and citrate supplementation (NCT03645785)
Timeframe: Day 1 (first void, 9-10 am, 1-2 pm and 5 pm) and Day 4 (first void, 9-10 am, 1-2 pm and 5 pm)
| Intervention | ratio (Mean) |
|---|---|
| 5pm Void Post | 0.658644 |
| 5p.m. Pre | 0.584115 |
| 1-2 pm Post | 0.562886 |
| 1-2pm Void Pre | 0.540394 |
| 9-10AM Post | 0.490685 |
| 9-10AM Pre | 0.441938 |
| First Void Pre | 0.423415 |
| First Void Post | 0.404892 |
pH at 4 voids throughout the day. Pre = baseline fluid intake; Post (NCT03645785)
Timeframe: Day 1 (first void, 9-10 am, 1-2 pm and 5 pm) and Day 4 (first void, 9-10 am, 1-2 pm and 5 pm)
| Intervention | pH (Mean) |
|---|---|
| 5pm Void Post | 6.52770 |
| 5p.m. Pre | 6.32645 |
| 1-2 pm Post | 6.34060 |
| 1-2pm Void Pre | 6.37845 |
| 9-10AM Post | 6.43430 |
| 9-10AM Pre | 6.24125 |
| First Void Pre | 6.08345 |
| First Void Post | 6.01865 |
SG at 4 voids throughout the day. Pre = baseline fluid intake; Post (NCT03645785)
Timeframe: Day 1 (first void, 9-10 am, 1-2 pm and 5 pm) and Day 4 (first void, 9-10 am, 1-2 pm and 5 pm)
| Intervention | g/mL (Mean) |
|---|---|
| 5pm Void Post | 1.01725 |
| 5p.m. Pre | 1.01525 |
| 1-2 pm Post | 1.01725 |
| 1-2pm Void Pre | 1.01850 |
| 9-10AM Post | 1.01950 |
| 9-10AM Pre | 1.02051 |
| First Void Pre | 1.02000 |
| First Void Post | 1.01825 |
(NCT03645785)
Timeframe: Over 4 day study period
| Intervention | mL (Mean) |
|---|---|
| Day 1 | 2416.854 |
| Day 2 | 2625.093 |
| Day 3 | 3116.562 |
| Day 4 | 3396.781 |
7 reviews available for citric acid, anhydrous and Hyperoxaluria
| Article | Year |
|---|---|
Metabolic diagnoses of recurrent stone formers: temporal, geographic and gender differences.
Topics: Citric Acid; Female; Global Health; Humans; Hypercalciuria; Hyperoxaluria; Kidney Calculi; Male; Met | 2020 |
Prevalence, pathophysiological mechanisms and factors affecting urolithiasis.
Topics: Alpha-Globulins; Animals; Calcium-Binding Proteins; Citric Acid; Extracellular Matrix Proteins; Hepa | 2018 |
Pharmacotherapy of kidney stones.
Topics: Animals; Citric Acid; Humans; Hypercalciuria; Hyperoxaluria; Kidney Calculi; Secondary Prevention; U | 2008 |
Pharmacotherapy of urolithiasis: evidence from clinical trials.
Topics: Citric Acid; Cystinuria; Humans; Hypercalciuria; Hyperoxaluria; Randomized Controlled Trials as Topi | 2011 |
Challenges in the diagnostic and therapeutic approach to nephrolithiasis.
Topics: Citric Acid; Diet; Humans; Hydrogen-Ion Concentration; Hypercalciuria; Hyperoxaluria; Nephrolithiasi | 2012 |
Urolithiasis in children: medical approach.
Topics: Calcium Oxalate; Calcium Phosphates; Child; Child, Preschool; Citric Acid; Cystinuria; Diagnostic Im | 2012 |
Kidney stones.
Topics: Calcium; Citric Acid; Colic; Glycoproteins; Humans; Hyperoxaluria; Kidney Calculi; Magnesium Compoun | 2004 |
4 trials available for citric acid, anhydrous and Hyperoxaluria
| Article | Year |
|---|---|
Oxalobacter formigenes: Opening the door to probiotic therapy for the treatment of hyperoxaluria.
Topics: Adult; Bifidobacterium; Calcium Oxalate; Citric Acid; Humans; Hyperoxaluria; Lactobacillus; Magnesiu | 2015 |
Results of medical treatment and metabolic risk factors in children with urolithiasis.
Topics: Adolescent; Calcium Metabolism Disorders; Child; Child, Preschool; Citric Acid; Cystinuria; Female; | 2011 |
Evaluation of urinary oxalate levels in patients receiving gastrointestinal lipase inhibitor.
Topics: Adult; Anti-Obesity Agents; Calcium; Citric Acid; Enzyme Inhibitors; Female; Humans; Hyperoxaluria; | 2008 |
Effect of unprocessed wheat bran on calciuria and oxaluria in patients with urolithiasis.
Topics: Adult; Aged; Calcium; Calcium, Dietary; Citrates; Citric Acid; Dietary Fiber; Female; Humans; Hydroc | 1990 |
33 other studies available for citric acid, anhydrous and Hyperoxaluria
| Article | Year |
|---|---|
Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
Topics: Adolescent; Adult; Age Factors; Aged; Body Mass Index; Calcium; Calcium Oxalate; Calcium Phosphates; | 2017 |
Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.
Topics: Adult; Aged; Body Mass Index; Citrates; Citric Acid; Cross-Sectional Studies; Female; Humans; Hyperc | 2013 |
[Secondary hyperoxaluria and nephrocalcinosis due to ethylene glycol poisoning].
Topics: Accidents, Home; Acidosis; Calcium Oxalate; Child, Preschool; Citric Acid; Ethylene Glycol; Fluid Th | 2013 |
Nephrocalcinosis induced by hyperoxaluria in rats.
Topics: Animals; Calcium; Citric Acid; Hyperoxaluria; Kidney; Male; Nephrocalcinosis; Oxalates; Random Alloc | 2013 |
Effect of sodium pentosan polysulfate and citrate on urinary stone formation in hyperoxaluric rats.
Topics: Animals; Anticoagulants; Citric Acid; Disease Models, Animal; Hyperoxaluria; Male; Pentosan Sulfuric | 1996 |
The characteristics of the stone and urine composition in Chinese stone formers: primary report of a single-center results.
Topics: Adult; Calcium Oxalate; Calcium Phosphates; China; Citric Acid; Cystine; Female; Humans; Hypercalciu | 2014 |
An update on metabolic assessment in patients with urinary lithiasis.
Topics: Adult; Citric Acid; Creatinine; Female; Humans; Hypercalciuria; Hyperoxaluria; Magnesium; Male; Prev | 2015 |
Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols.
Topics: Calcium Oxalate; Calcium, Dietary; Chelating Agents; Citric Acid; Clinical Protocols; Computer Simul | 2014 |
A London experience 1995-2012: demographic, dietary and biochemical characteristics of a large adult cohort of patients with renal stone disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Citric Acid; Cohort Studies; Cross-Sectional Studies; Di | 2015 |
Metabolic disorders in Turkish children with urolithiasis.
Topics: Adolescent; Age Factors; Child; Child, Preschool; Citric Acid; Cystinuria; Female; Humans; Hypercalc | 2015 |
Metabolic evaluation in patients with infected nephrolithiasis: Is it necessary?
Topics: Adolescent; Adult; Aged; Apatites; Calcium Oxalate; Citric Acid; Female; Follow-Up Studies; Humans; | 2016 |
Clinical and metabolic features of urolithiasis and microlithiasis in children.
Topics: Calcium; Child; Child, Preschool; Citric Acid; Cystinuria; Female; Humans; Hypercalciuria; Hyperoxal | 2009 |
Urolithiasis in the first year of life.
Topics: Blood Chemical Analysis; Child, Preschool; Citric Acid; Cystinuria; Female; Humans; Hypercalciuria; | 2010 |
Clinical manifestations and etiology of renal stones in children less than 14 years age.
Topics: Adolescent; Child; Child, Preschool; Citric Acid; Cystinuria; Dysuria; Female; Fever; Genetic Predis | 2010 |
Metabolic factors associated with urinary calculi in children.
Topics: Adolescent; Calcium; Child; Child, Preschool; Citric Acid; Cystinuria; Female; Humans; Hypercalciuri | 2010 |
Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery.
Topics: Citric Acid; Cross-Sectional Studies; Female; Gastric Bypass; Humans; Hyperoxaluria; Kidney Diseases | 2010 |
Nephrolithiasis in medullary sponge kidney: evaluation of clinical and metabolic features.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Citric Acid; Diuresis; Female; Humans; Hypercalciuria; H | 2012 |
Hypercalciuria, hyperoxaluria, and hypocitraturia screening from random urine samples in patients with calcium lithiasis.
Topics: Adult; Citric Acid; Female; Humans; Hypercalciuria; Hyperoxaluria; Kidney Calculi; Male; Middle Aged | 2012 |
Abnormalities of 24-hour urine composition in first-time and recurrent stone-formers.
Topics: Adult; Aged; Citric Acid; Female; Humans; Hypercalciuria; Hyperoxaluria; Linear Models; Male; Middle | 2012 |
Effects of dietary interventions on 24-hour urine parameters in patients with idiopathic recurrent calcium oxalate stones.
Topics: Adult; Calcium; Calcium Oxalate; Citric Acid; Diet; Female; Humans; Hypercalciuria; Hyperoxaluria; K | 2013 |
Risk factors determining active urinary stone formation in patients with urolithiasis.
Topics: Adult; Calcium; Citric Acid; Female; Humans; Hyperoxaluria; Male; Middle Aged; Recurrence; Retrospec | 2005 |
Ethnic background has minimal impact on the etiology of nephrolithiasis.
Topics: Adult; Aged; Calcium; Citric Acid; Cross-Sectional Studies; Ethnicity; Female; Gout; Humans; Hyperox | 2005 |
Oral L-arginine supplementation ameliorates urinary risk factors and kinetic modulation of Tamm-Horsfall glycoprotein in experimental hyperoxaluric rats.
Topics: Animals; Arginine; Biomarkers; Calcium Compounds; Calcium Oxalate; Citric Acid; Clinical Enzyme Test | 2005 |
[Metaphylaxis of recurrent renal calcium stones].
Topics: Calcium Oxalate; Calcium Phosphates; Citric Acid; Humans; Hypercalciuria; Hyperoxaluria; Hyperuricem | 2007 |
Excessive urinary oxalate excretion occurs in long-term TPN patients both with and without ileostomies.
Topics: Absorption; Adult; Aged; Citrates; Citric Acid; Female; Glomerular Filtration Rate; Humans; Hyperoxa | 1995 |
[A metabolic study of urolithiasis. Specificity, sensitivity, efficacy and reproducibility].
Topics: Absorption; Adolescent; Adult; Aged; Calcium; Citrates; Citric Acid; Clinical Protocols; Creatinine; | 1995 |
Effect of L-cysteine on some urinary risk factors in experimental hyperoxaluric rats.
Topics: Animals; Calcium; Calcium Oxalate; Citrates; Citric Acid; Cysteine; Glycolates; Glyoxylates; Hyperox | 1996 |
'Bad dietary habits' and recurrent calcium oxalate nephrolithiasis.
Topics: Adult; Calcium; Calcium Oxalate; Citric Acid; Feeding Behavior; Humans; Hyperoxaluria; Kidney Calcul | 1998 |
Urolithiasis.
Topics: Calcium; Citric Acid; Humans; Hyperoxaluria; Recurrence; Uric Acid; Urinary Calculi | 1998 |
N-acetyl-beta-D-glucosaminidase excretion in healthy children and in pediatric patients with urolithiasis.
Topics: Acetylglucosaminidase; Adolescent; Biomarkers; Calcium; Child; Child, Preschool; Citric Acid; Creati | 1998 |
Phenotypic expression of primary hyperoxaluria: comparative features of types I and II.
Topics: Adolescent; Adult; Calcium; Calcium Oxalate; Child; Child, Preschool; Citric Acid; Crystallization; | 2001 |
Twenty-four-hour urine chemistries and the risk of kidney stones among women and men.
Topics: Adult; Calcium; Citric Acid; Cohort Studies; Female; Follow-Up Studies; Humans; Hyperoxaluria; Kidne | 2001 |
Calcium citrate for vulvar vestibulitis. A case report.
Topics: Administration, Oral; Adult; Antacids; Citrates; Citric Acid; Female; Humans; Hyperoxaluria; Pain; P | 1991 |